< 1 minute read
Dec. 20, 2021
A Brain-Penetrant, Paradox-Breaking BRAF Inhibitor from Roche
"compound Ia"
oral BRAF inhibitor, brain penetrant effective in A375-derived mouse models from prior paradox inducing BRAF inhibitors Clinical Cancer Research Roche
Reviewer: